Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

169.96
Delayed Data
As of 4:00pm ET
 +0.12 / +0.07%
Today’s Change
138.83
Today|||52-Week Range
191.10
+16.24%
Year-to-Date

Today’s Trading

Previous close169.84
Today’s open169.86
Day’s range169.33 - 170.73
Volume1,533,133
Average volume (3 months)2,593,832
Market cap$123.3B
Dividend yield2.71%
Data as of 4:00pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+8.88%
Earnings growth (next 5 years)+4.17%
Revenue growth (last year)+6.31%
P/E ratio15.4
Price/Sales4.86
Price/Book4.20

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.31+0.43%
BIIBBiogen+0.74+0.24%
ILMNIllumina Inc+3.30+1.56%
----
Data as of 4:00pm ET, 11/22/2017

Financials

Next reporting dateJanuary 25, 2018
EPS forecast (this quarter)$3.03
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts